HNL News

June 29, 2022

Automation in the Clinical Laboratory

Clinical laboratory automation is essential to deliver high quality results in the most cost effective and efficient way.  Automation requires minimal operator intervention and helps to increase productivity, tracking of specimens within the laboratory, decreased turnaround times, improvements in specimen handling, improved laboratory safety, and minimizes errors.
Read More
June 17, 2022

LYME Disease

As you continue to spend more time outside enjoying the weather, you’ll be sharing your space with some critters you’ll want to be aware of. Deer ticks can carry the bacteria that causes Lyme disease, which can have a critical impact on your health if untreated.
Read More
June 15, 2022

Men's Health Month

In 1994, Congress designated the month of June as Men's Health Month to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys.
Read More
June 10, 2022

LGBTQ Pledge

HNL Lab Medicine believes the diversity of our workforce makes us stronger. We are committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion. We strive to attract, develop, and retain a diverse and inclusive workforce.
Read More
June 09, 2022

HNL Lab Medicine Artwork Contest Celebrates Healthcare Heroes

Throughout the month of May, HNL Lab Medicine, a regional leader in high-quality, innovative laboratory medicine services, announced an artwork contest for children in grades K-8. The goal of this contest was to promote awareness of the healthcare field, encourage creativity, and include a valuable connection to the community in each of HNL’s patient service centers.
Read More

Shanth A. Goonewardene


Vice Chair Quality and Clinical Operations; Chief, Section of Gastrointestinal Pathology

Dr. Goonewardene received his MD from Jefferson Medical College. He completed his pathology residency and surgical pathology fellowship (with focus in Gastrointestinal Pathology) at Thomas Jefferson University Hospital, Philadelphia, Pa. He then completed a Fellowship in Cytopathology at the Hospital of the University of Pennsylvania, Philadelphia, Pa. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in Cytopathology. Dr. Goonewardene serves as Director of the Anatomic Pathology Quality Assurance Committee at Lehigh Valley Health Network. His research and publications focus on gastrointestinal pathology. He is currently investigating the use of molecular markers in increasing the sensitivity of detecting pancreatic adenocarcinoma in fine needle aspiration cytology specimens. Dr. Shanth Goonewardene is a Clinical Assistant Professor at University of South Florida (USF), Morsani College of Medicine.



The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients t reated with surgery alone.
Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.Cancer. 2004 Jun 1;100(11):2317-27. PMID: 15160334 Free Article

Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL,Goonewardene S, Fogt F. Mod Pathol. 2001 Aug;14(8):748-51. PMID:11504833 Free Article

Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions.
Zimmerman RL, Goonewardene S,Fogt F. Anal Quant Cytol Histol. 2000 Oct;22(5):353-7. PMID:11064810

Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL, Fogt F, Goonewardene S. Cancer. 2000 Aug 25;90(4):230-4. PMID:10966563